Explore the words cloud of the ARM-B project. It provides you a very rough idea of what is the project "ARM-B" about.
The following table provides information about the project.
| Coordinator |
ALLOGEN BIOTECH LIMITED
Organization address contact info |
| Coordinator Country | Ireland [IE] |
| Project website | http://www.allogenbiotech.com |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-SMEInst-2018-2020-1 |
| Funding Scheme | SME-1 |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-06-01 to 2018-08-31 |
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | ALLOGEN BIOTECH LIMITED | IE (DUBLIN) | coordinator | 50˙000.00 |
Allogen Biotech is innovating the ARM-B allergy diagnostics patch technology for use in the healthcare sector and home-test markets. The company’s advanced biosensor concept draws on the simplicity and reliability of traditional skin-prick procedures, yet provides improved clinical outcomes and patient experience. The Allogen innovation is engineered as 50 mm stick-on disc-shaped patch, composed of a microarray device, which identify panels of allergic reactions. Each type of allergic response is interpreted as electrical impedance changes at individual biosensors. The allergy specialist acquires the test results in 5 minutes on a wide panel of common or specific allergens. The sensors register the degree of severity of an allergic reaction and may provide further information on specific testing. The ARM-B system offers unique advantages for the allergy therapist and patients alike. The patch device is non-intrusive – no need to pen-mark or prick large areas of skin: ARM-B microarray extends only 30 mm. The tine-microelectrode structure of the biosensor component ensures ultra-low invasiveness, penetrating only a few hundred microns of epidermis, not millimetre skin-prick depths. Therefore the ARM-B test offers a pain free consultation. The in vivo patch uses only picomole/nL, of a purified allergen microgel, minimising the risk of adverse side effects prevalent with skin-pricks – viz. nausea, raining, malaise. The device offers a large allergy dataset, a consequence of the microarray concept. The sensors are quantitative, so data on degree of allergic response or severity is collated. The solution to skin-oriented allergy diagnostics is applicable to several alternative market segments, not only accredited clinics and general practice with specialist allergy practitioners, but also in the self-test or home-use setting. ARM-B is a high value, low-cost solution for allergy diagnostics.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ARM-B" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ARM-B" are provided by the European Opendata Portal: CORDIS opendata.
Redefining Drone Safety and Autonomous Operation for Indoor Commercial Applications
Read MoreA digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat
Read MoreMicrobial production of custom-made, pure and sustainable anthocyanins
Read More